Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...

ALNY reports better-than-expected fourth-quarter results as both earnings and revenues beat estimates driven by higher ...

British stocks had a mixed finish on Friday due to a stronger sterling and losses in the pharma sector. While the FTSE 100 ...

Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug ...

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

The Indian stock market witnessed a flat closing on Thursday, as initial bullish attempts failed to sustain, giving way to ...

Sensex falls over 600 points, Nifty below 22,800 as Adani Ports, Sun Pharma lead losses. Monitor market trends now!

Glenmark Pharmaceuticals (NSE: GLEN) Inc., USA (Glenmark) has announced the launch of Latanoprost Ophthalmic Solution, 0.005% ...

Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...

The pound has risen to its highest value this year as the US Treasury said the Trump administration is considering currency ...

CRL's solid prospects in the DSA segment and strategic partnerships present a promising opportunity for investors.

Following the earnings announcement, WST stock plummeted 38% due to its disappointing guidance. Over a broader timeframe, its ...